Evgeniya Grineva

Evgeniya Grineva

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Dmitry KarpovDmitry Karpov
Dmitry Karpov
PSPavel Spirin
Pavel Spirin
AZAndrey O. Zheltukhin
Andrey O. Zheltukhin
VTVera V. Tutyaeva
Vera V. Tutyaeva
OZOlga L. Zinovieva
Olga L. Zinovieva
NLNikolai A. Lisitsyn
Nikolai A. Lisitsyn
Overcoming drug resistance of cancer cells is the major challenge in molecular oncology. Here, we demonstrate that long non-coding RNA LINC00973 is up-regulated in normal and cancer cells of different origins upon treatment with different chemotherapeutics. Bioinformatics analysis shows that this is a consequence of DNA damage response pathway activation or mitotic arrest. Knockdown of LINC0973 decreases p21 levels, activates cellular proliferation of cancer cells, and suppresses apoptosis of drug-treated cells. We have found that LINC00973 strongly increases p21 protein content, possibly by blocking its degradation. Besides, we have found that ectopic over-expression of LINC00973 inhibits formation of the pro-survival p53-Ser15-P isoform, which preserves chromosome integrity. These results might open a new approach to the development of more efficient anti-cancer drugs.

14 March 2023 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
DSDaria S. Spasskaya
Daria S. Spasskaya
KKKirill A. Kulagin Kulagin
Kirill A. Kulagin Kulagin
EGEvgeniya Grineva
Evgeniya Grineva
POPamila J. Osipova
Pamila J. Osipova
SPSvetlana Poddubko
Svetlana Poddubko
Dmitry KarpovDmitry Karpov
Dmitry Karpov
Various external and internal factors damaging DNA constantly disrupt the stability of the genome. Cells use numerous dedicated DNA repair systems to detect damage and restore genomic integrity in a timely manner. Ribonucleotide reductase (RNR) is a key enzyme providing dNTPs for DNA repair. Molecular mechanisms of indirect regulation of yeast RNR activity are well understood, whereas little is known about its direct regulation. The study was aimed at elucidation of the proteasome-dependent mechanism of direct regulation of RNR subunits in Saccharomyces cerevisiae. Proteome analysis followed by Western blot, RT-PCR, and yeast plating analysis showed that upregulation of RNR by proteasome deregulation is associated with yeast hyper resistance to 4-nitroquinoline-1-oxide (4-NQO), a UV-mimetic DNA-damaging drug used in animal models to study oncogenesis. Inhibition of RNR or deletion of RNR regulatory proteins reverses the phenotype of yeast hyper resistance to 4-NQO. We have shown for the first time that the yeast Rnr1 subunit is a substrate of the proteasome, which suggests a common mechanism of RNR regulation in yeast and mammals.